Identifying biomarkers of treatment response to ciclosporin in atopic dermatitis through multiomic predictive modelling: DERMATOMICS study protocol

Introduction There is a need to optimise the management of atopic dermatitis (AD), improving the efficacy of treatments and reducing the toxicity associated with them. Although the efficacy of ciclosporine (CsA) in the treatment of AD has been thoroughly documented in the literature, the optimal dos...

Full description

Bibliographic Details
Main Authors: Alberto M Borobia, Antonio J Carcas, Ana Martínez-Feito, Alicia Marín-Candón, Irene García-García, Pedro Arias, Lucía Díaz-García, Rosa Feltes Ochoa, Natalia Hernández Cano, Pedro Herranz Pinto, María Jiménez González, Eduardo López -Granados, Ander Mayor-Ibarguren, Rocío Rosas-Alonso, Enrique Seco-Meseguer
Format: Article
Language:English
Published: BMJ Publishing Group 2023-07-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/7/e072350.full